Yuri Nishino
Kurume, 8300011, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis.
Journal: International journal of molecular sciences
Published: February 23, 2025
Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product-receptor axis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 31, 2024
Sulforaphane inhibits cardiac fibrosis induced by advanced glycation end product-receptor axis through its anti-oxidative property.
Journal: Acta diabetologica
Published: November 23, 2024
Glucagon like peptide-1 modulates urinary sodium excretion in diabetic kidney disease via ENaC activation.
Journal: Scientific reports
Published: August 10, 2024
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: November 02, 2022
Increased Urinary Levels of Pentosidine Measured by a Newly Developed Enzyme-Linked Immunosorbent Assay Are Independently Correlated with Fracture After Fall.
Journal: Rejuvenation research
Published: November 30, 2021
DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
Journal: Oxidative medicine and cellular longevity
Published: March 04, 2021
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
Journal: Diabetes & vascular disease research
Published: February 04, 2021
Albuminuria-lowering effect of sodium-glucose cotransporter 2 inhibitors could be partly attributable to the attenuation of tubular damage in type 2 diabetic patients.
Journal: Diabetes/metabolism research and reviews
Published: October 15, 2019
Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice.
Journal: Journal of oncology
Published: November 19, 2018
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Journal: Diabetes
Published: October 21, 2016
Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: January 14, 2016
Last Updated: 09/26/2026